The European Molecular Genetics Quality Network (EMQN) is a provider of External Quality Assessment (EQA) services which are essential for any laboratory seeking to maintain and provide a quality service. The organization was established in 1998 after a successful pilot trial of a Huntington disease EQA scheme the previous year. From January 1999 to March 2002, the network was supported by a grant from the European Commission under the Standards Measurement and Testing Programme (contract number SMT4-CT98-7515). Since April 2002, EMQN activities have been supported by subscriptions from EQA scheme participants and currently EMQN offers molecular genetics, molecular pathology, and technique specific EQA schemes for molecular testing.
The EMQN is based at the Genetic Medicine Service, St Mary's Hospital, Manchester, The United Kingdom. Our Host organisation is Central Manchester University Hospitals NHS Foundation Trust (CMFT).